Skip to main content
. 2024 Nov 1. Online ahead of print. doi: 10.1039/d4md00670d

Fig. 11. In vivo antibacterial activity of 5p (3.0 mg mL−1 and 6.0 mg mL−1) against MRSA (n = 6).

Fig. 11